Evidence map›Paper›PMID 33971913›Full record

Trial reportImplementation science : IS2021

Implementation and sustainability factors of two early-stage breast cancer conversation aids in diverse practices.

Danielle Schubbe, Renata W Yen, Catherine H Saunders, Glyn Elwyn, Rachel C Forcino, A James O'Malley, Mary C Politi, Julie Margenthaler, Robert J Volk, Karen Sepucha and 8 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Implementation science : IS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03136367 (Comparative Effectiveness of Encounter Decision Aids for Early-Stage Breast Cancer Across Socioeconomic Strata), which is not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03136367 nacompletednot on this map

Comparative Effectiveness of Encounter Decision Aids for Early-Stage Breast Cancer Across Socioeconomic Strata

TypeinterventionalSponsorDartmouth-Hitchcock Medical CenterRan2017 to 2019Enrolled571ConditionsBreast CancerArmsOption Grid, Picture Option Grid
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 4 countries.

Danielle SchubbeThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA.
Renata W YenThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA.
Catherine H SaundersThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA.
Glyn ElwynThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA.
Rachel C ForcinoThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA.
A James O'MalleyThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA.
Mary C PolitiDepartment of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Julie MargenthalerDepartment of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Robert J VolkDivision of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Karen SepuchaDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Elissa OzanneUniversity of Utah, Salt Lake City, UT, USA.
Sanja Percac-LimaMassachusetts General Hospital's Chelsea Healthcare Center, Chelsea, MA, USA.
Ann BradleyThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA.
Courtney GoodwinDepartment of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Maria van den MuijsenberghRadboudUMC, Nijmegen, The Netherlands.
Johanna W M AartsAmsterdamUMC, Amsterdam, The Netherlands.
Peter ScaliaThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA.
Marie-Anne DurandThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA. marie-anne.durand@dartmouth.edu.ORCID 0000-0002-8173-1993
Dartmouth College · USWashington University in St. Louis · USMassachusetts General Hospital · USAmsterdam University Medical Centers · NLDartmouth Institute for Health Policy and Clinical Practice · USRadboud University Nijmegen · NLThe University of Texas MD Anderson Cancer Center · USUniversity of Utah · US

Funding

Patient-Centered Outcomes Research Institute CDR-1511-32975
6 · The paper itself

Abstract

backgroundConversation aids can facilitate shared decision-making and improve patient-centered outcomes. However, few examples exist of sustained use of conversation aids in routine care due to numerous barriers at clinical and organizational levels. We explored factors that will promote the sustained use of two early-stage breast cancer conversation aids. We examined differences in opinions between the two conversation aids and across socioeconomic strata.

methodsWe nested this study within a randomized controlled trial that demonstrated the effectiveness of two early-stage breast cancer surgery conversation aids, one text-based and one picture-based. These conversation aids facilitated more shared decision-making and improved the decision process, among other outcomes, across four health systems with socioeconomically diverse patient populations. We conducted semi-structured interviews with a purposive sample of patient participants across conversation aid assignment and socioeconomic status (SES) and collected observations and field notes. We interviewed trial surgeons and other stakeholders. Two independent coders conducted framework analysis using the NOrmalization MeAsure Development through Normalization Process Theory. We also conducted an inductive analysis. We conducted additional sub-analyses based on conversation aid assignment and patient SES.

resultsWe conducted 73 semi-structured interviews with 43 patients, 16 surgeons, and 14 stakeholders like nurses, cancer center directors, and electronic health record (EHR) experts. Patients and surgeons felt the conversation aids should be used in breast cancer care in the future and were open to various methods of giving and receiving the conversation aid (EHR, email, patient portal, before consultation). Patients of higher SES were more likely to note the conversation aids influenced their treatment discussion, while patients of lower SES noted more influence on their decision-making. Intervention surgeons reported using the conversation aids did not lengthen their typical consultation time. Most intervention surgeons felt using the conversation aids enhanced their usual care after using it a few times, and most patients felt it appeared part of their normal routine.

conclusionsKey factors that will guide the future sustained implementation of the conversation aids include adapting to existing clinical workflows, flexibility of use, patient characteristics, and communication preferences.

trial registrationClinicalTrials.gov Identifier: NCT03136367 , registered on May 2, 2017.

Indexed as

Breast NeoplasmsCommunicationDecision MakingDecision Making, SharedDecision Support TechniquesFemaleHumansPatient ParticipationBreast cancerConversation aidDecision aidEncounter decision aidEncounter patient decision aidHealth communicationImplementationNormalization Process TheoryQualitative researchShared decision-making

Identifiers

PMID33971913
PMCPMC8108365
OpenAlexW3159045415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.